Anxiety • MindMed

Now Enrolling
Written By Kirsten Hirst

MM120-300

About the Study

This study is designed to evaluate the efficacy of a single dose of MM-120 (D-lysergic acid diethylamide D-tartrate), versus placebo, for the treatment of anxiety symptoms.

This study is sponsored by Mind Medicine, Inc.

Eligibility

You may be eligible to participate in this study if you:

  • are between the ages of 18-74 years old

  • are experiencing anxiety symptoms

  • have been diagnosed with Generalized Anxiety Disorder (GAD)

  • can spend the day at our facility for a 12-hour dosing session

Apply Today

If you are interested in participating in this clinical trial, please call our friendly staff at 801-871-5516 today. You can also fill out the contact form below.

 
Kirsten Hirst
Previous

PTSD • Transcend
Next

Depression • J&J